Literature DB >> 15514581

Laboratory exposure to Burkholderia pseudomallei--Los Angeles, California, 2003.

.   

Abstract

On July 26, 2003, the Los Angeles County Department of Health Services (LACDHS) received a report that a local clinical laboratory had isolated from specimens Burkholderia pseudomallei, a category B biologic terrorism agent and the causative organism for melioidosis, which is endemic to certain tropical areas. Because laboratory workers had manipulated cultures of the organism, CDC was asked to assist in the subsequent investigation. This report summarizes the results of that investigation, which included assessment of laboratory exposures, postexposure chemoprophylaxis, and serologic testing of exposed laboratory workers. The findings underscore the need to reinforce proper laboratory practices and the potential benefits of chemoprophylaxis after laboratory exposures.

Entities:  

Mesh:

Year:  2004        PMID: 15514581

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  11 in total

1.  Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei.

Authors:  Ryan T Novak; Mindy B Glass; Jay E Gee; Daniel Gal; Mark J Mayo; Bart J Currie; Patricia P Wilkins
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Accidental exposure to Burkholderia pseudomallei in the laboratory in the era of matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Tanis C Dingle; Susan M Butler-Wu; April N Abbott
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

3.  Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei.

Authors:  Sharon J Peacock; Herbert P Schweizer; David A B Dance; Theresa L Smith; Jay E Gee; Vanaporn Wuthiekanun; David DeShazer; Ivo Steinmetz; Patrick Tan; Bart J Currie
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

Review 4.  Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory.

Authors:  Peera Hemarajata; Jonathan D Baghdadi; Risa Hoffman; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2016-09-21       Impact factor: 5.948

5.  Clinical problem-solving. Beware of first impressions.

Authors:  Oluwaseun O Falade; Emmanuel S Antonarakis; Daniel R Kaul; Sanjay Saint; Patrick A Murphy
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

6.  Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report.

Authors:  Dimas Mateos Corral; Allan L Coates; Yvonne C W Yau; Raymond Tellier; Mindy Glass; Steven M Jones; Valerie J Waters
Journal:  Can Respir J       Date:  2008 Jul-Aug       Impact factor: 2.409

7.  Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis.

Authors:  Allen C Cheng; Wirongrong Chierakul; Wipada Chaowagul; Ploenchan Chetchotisakd; Direk Limmathurotsakul; David A B Dance; Sharon J Peacock; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

8.  Melioidosis diagnostic workshop, 2013.

Authors:  Alex R Hoffmaster; David AuCoin; Prasith Baccam; Henry C Baggett; Rob Baird; Saithip Bhengsri; David D Blaney; Paul J Brett; Timothy J G Brooks; Katherine A Brown; Narisara Chantratita; Allen C Cheng; David A B Dance; Saskia Decuypere; Dawn Defenbaugh; Jay E Gee; Raymond Houghton; Possawat Jorakate; Ganjana Lertmemongkolchai; Direk Limmathurotsakul; Toby L Merlin; Chiranjay Mukhopadhyay; Robert Norton; Sharon J Peacock; Dionne B Rolim; Andrew J Simpson; Ivo Steinmetz; Robyn A Stoddard; Martha M Stokes; David Sue; Apichai Tuanyok; Toni Whistler; Vanaporn Wuthiekanun; Henry T Walke
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

9.  The Identification and Differentiation between Burkholderia mallei and Burkholderia pseudomallei Using One Gene Pyrosequencing.

Authors:  Damian H Gilling; Vicki Ann Luna; Cori Pflugradt
Journal:  Int Sch Res Notices       Date:  2014-10-02

10.  Imported melioidosis, Israel, 2008.

Authors:  Avivit Cahn; Benjamin Koslowsky; Ran Nir-Paz; Violeta Temper; Nurit Hiller; Alla Karlinsky; Itzhak Gur; Carlos Hidalgo-Grass; Samuel N Heyman; Allon E Moses; Colin Block
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.